AMED - Amedisys profit beats by $0.24 revenue misses by $25.23M 2022 guidance below estimates
- Amedisys press release ( NASDAQ: AMED ): Q2 Non-GAAP EPS of $1.47 beats by $0.24 .
- Revenue of $557.89M (-1.1% Y/Y) misses by $25.23M .
- Updated 2022 Guidance
- Adjusted net service revenue is anticipated to be in the range of $2.290 billion to $2.310 billion vs $2.35B consensus.
- Adjusted diluted earnings per share is anticipated to be in the range of $5.23 to $5.45 based on an estimated 32.8 million shares outstanding. Consensus estimate $5.31.
For further details see:
Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates